Search
Searching Content indexed under Food and Drugs Law by Karen Hewitt ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
美国阿玛林公司与美国食品药品管理局达成药品标示外推广的和解协议
On March 8, 2016, Amarin Pharma, Inc. reached a noteworthy settlement in its lawsuit against the U.S. Food and Drug Administration ("FDA") to protect its First Amendment right to promote the drug Vascepa for nonapproved, off-label uses.
United States
14 Apr 2016
2
Amarin And FDA Agree To Landmark Settlement On Off-Label Promotion
The FDA approved Vascepa (icosapent ethyl) capsules to reduce triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia.
United States
17 Mar 2016
Links to Result pages
 
1